In silico investigation of action mechanism of four novel angiotensin-I converting enzyme inhibitory peptides modified with Trp

Journal of Functional Foods

Volumn 17, Issue , 2015, Pages 632-639

  Xie, Cheng liang ^a,d   Choung, Se young ^b   Cao, Guang ping ^c   Lee, Keun Woo ^c   Choi, Yeung Joon ^a  

^a Gyeongsang National University   (South Korea)

^b Kyung Hee University   (South Korea)

^c Department of Biochemistry Division of Applied Life Science (BK21 Plus Program) Systems and Synthetic Agrobiotech Center (SSAC) Plant Molecular Biology and Biotechnology Research Center (PMBBRC)   (South Korea)

^d Gyeongsang National University School of Medicine   (South Korea)

Author keywords

Angiotensin I converting enzyme; Molecular docking; Molecular dynamics simulation; Peptide

Indexed keywords

OSTREIDAE;

EID: 84938876106     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2015.06.016     Document Type: Article

References (33)

1. Acharya K.R., Sturrock E.D., Riordan J.F., Ehlers M.R. ACE revisited: A new target for structure-based drug design. Nature Reviewers Drug Discovery 2003, 2:891-902.
2. Alonso H., Bliznyuk A.A., Gready J.E. Combining docking and molecular dynamic simulations in drug design. Medicinal Research Reviews 2006, 26:531-568.
3. Berendsen H.J.C., Postma J.P.M., van Gunsteren W.F., Hermans J. Interaction models for water in relation to protein hydration. Intermolecular forces. The Jerusalem Symposia on Quantum Chemistry and Biochemistry 1981, 14:331-342.
4. Bussi G., Donadio D., Parrinello M. Canonical sampling through velocity rescaling. The Journal of Chemical Physics 2007, 126:1-8.
5. Castellano P., Aristoy M., Sentandreu M.A., Vignolo G. Peptides with angiotensin I converting enzyme (ACE) inhibitory activity generated from porcine skeletal muscle proteins by the action of meat-borne Lactobacillus. Journal of Proteomics 2013, 89:183-190.
6. Cerny J., Hobza P. Non-covalent interactions in biomacromolecules. Physical Chemistry Chemical Physics 2007, 9:5291-5303.
7. Cushman D.W., Cheung H.S., Sabo E.F., Ondetti M.A. Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercapto-alkanoyl amino acids. Biochemistry 1977, 16:5484-5491.
8. De Leo F., Panarese S., Gallerani R., Ceci L.R. Angiotensin converting enzyme (ACE) inhibitory peptides: Production and implementation of functional food. Current Pharmaceutical Design 2009, 15:3622-3643.
9. Essmann U., Perera L., Berkowitz M.L., Darden T., Lee H., Pedersen L.G. A smooth particle mesh Ewald method. The Journal of Chemical Physics 1995, 103:8577-8593.
10. Fields G.B., Lauer-Fields J.L., Liu R., Barany G. Principles and practice of solid-phase peptide synthesis. Synthetic peptides: A user's guide 2002, 93-219. Oxford University Press, Inc, New York. G.A. Grant (Ed.).
11. Hess B., Bekker H., Berendsen H.J.C., Fraaije J.G.E.M. LINCS: A linear constraint solver for molecular simulations. Journal of Computational Chemistry 1997, 18:1463-1472.
12. Holder A., Birke A., Eisele T., Klaiber I., Fischer L., Hinrichs J. Selective isolation of angiotensin I-converting enzyme-inhibitory peptides from micellar casein and β-casein hydrolysates via ultrafiltration. International Dairy Journal 2013, 31:34-40.
13. Jorgensen W.L., Chandrasekhar J., Madura J.D., Impey R.W., Klein M.L. Comparison of simple potential functions for simulating liquid water. The Journal of Chemical Physics 1983, 79:926-935.
14. Kellenberger E., Rodrigo J., Muller P., Rognan D. Comparative evaluation of eight docking tools for docking and virtual screening accuracy. Proteins 2004, 57:225-242.
15. Kulkarni A., Han Y., Hopfinger A.J. Predicting Caco-2 cell permeation coefficients of organic molecules using membrane-interaction QSAR analysis. Journal of Chemical Information and Modelling 2002, 42:331-342.
16. Lindahl E., Hess B., van der Spoel D. Gromacs 3.0: A package for molecular simulation and trajectory analysis. Molecular Modeling Annual 2001, 7:306-317.
17. Majumder K., Chakrabarti S., Morton J.S., Panahi S., Kaufman S., Davidge S.T., Wu J. Egg-derived ACE-inhibitory peptides IQW and LKP reduce blood pressure in spontaneously hypertensive rats. Journal of Functional Foods 2015, 13:50-60.
18. Natesh R., Schwager S.L., Evans H.R., Sturrock E.D., Acharya K.R. Structural details on the binding of antihypertensive drugs captopril and enalaprilat to human testicular angiotensin I-converting enzyme. Biochemistry 2004, 43:8718-8724.
19. Natesh R., Schwager S.L., Sturrock E.D., Acharya K.R. Crystal structure of the human angiotensin-converting enzyme-lisinopril complex. Nature 2003, 421:551-554.
20. Parrinello M., Rahman A. Polymorphic transitions in single crystals: A new molecular dynamics method. Journal of Applied Physics 1981, 52:7182-7190.
21. Seki E., Osajima K., Matsufuji H., Matsui T., Osajima Y. Val-Tyr, and angiotensin-I converting enzyme inhibitor from sardines that have resistance to gastrointestinal proteases. Journal of Agricultural Chemical Society of Japan 1995, 69:1013-1020.
22. Shamloo M., Eck P., Beta T. Angiotensin converting enzyme inhibitory peptides derived from cereals. Journal of Human Nutrition & Food Science 2015, 3:1057-1066.
23. Silva A.W.S.D., Vranken W.F. ACPYPE-Antechamber python parser interface. BMC Research Notes 2012, 5:367-375.
24. Watermeyer J.W., Kroger W.L., O'Neill H.G., Sewell B.T., Sturrock E.D. Characterization of domain-selective inhibitor binding in angiotensin converting enzyme using a novel derivative of lisinopril. Biochemical Journal 2010, 428:67-74.
25. Wu J., Aluko R.E., Muir A.D. Improved method for direct high-performance liquid chromatography assay of angiotensin-converting enzyme-catalyzed reactions. Journal of Chromatography. A 2002, 950:125-130.
26. Wu J., Aluko R.E., Nakai S. Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure-activity relationship study of di-and tripeptides. Journal of Agricultural and Food Chemistry 2006, 54:732-738.
27. Wu J., Aluko R.E., Nakai S. Structural requirements of angiotensin-I converting enzyme inhibitory peptides: Quantitative structure-activity relationship modeling of peptides containing 4-10 amino acid residues. QSAR & Combinational Science 2006, 25:873-880.
28. Wu S., Feng X., Lan X., Xu Y., Liao D. Purification and identification of angiotensin-I converting enzyme (ACE) inhibitory peptide from lizard fish (Saurida elongata) hydrolysate. Journal of Functional Foods 2015, 13:295-299.
29. Xie C.L., Kim J.S., Ha J.M., Choung S.Y., Choi Y.J. Angiotensin-I converting enzyme inhibitor derived from cross-linked oyster protein. Biomed Research International 2014, 2014:379234. 10.1155/2014/379234.
30. Xing L., Hodgkin E., Liu Q., Sedlock D. Evaluation and application of multiple scoring functions for a virtual screening experiment. Journal of Computer-Aided Molecular Design 2004, 18:333-344.
31. Yamada A., Sakurai T., Ochi D., Mitsuyama E., Yamauchi K., Abe F. Novel angiotensin I converting enzyme inhibitory peptide derived from bovine casein. Food Chemistry 2013, 141:3781-3789.
32. Yamada Y., Matoba N., Usui H., Onishi K., Yoshikawa M. Design of a highly potent anti-hypertensive peptide based on ovokinin (2-7). Bioscience, Biotechnology, and Biochemistry 2002, 66:1213-1217.
33. Zhou M., Du K., Ji P., Feng W. Molecular mechanism of the interactions between inhibitory tripeptides and angiotensin-converting enzyme. Biophysical Chemistry 2012, 168:60-66.